To be effective, a cancer vaccine needs to induce vigorous and sustained T-cell-based immune responses.35 36 To achieve this, delivery of the vaccine to address and co-ordinately activate DCs and CD8+cytotoxic T-cells is essential. The gene discussed is CD8A; the disease is cancer.